88 related articles for article (PubMed ID: 4233209)
1. [Histochemical studies on the effect of antibody and serum factors on ascites tumor cells and mast cells].
Keller R
Bibl Haematol; 1967; 27():95-101. PubMed ID: 4233209
[No Abstract] [Full Text] [Related]
2. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
Goff MM; Armentrout SA
J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
[TBL] [Abstract][Full Text] [Related]
3. [Histochemical studies on the degranulation of the mast cell].
Aoki K; Saito T
Arerugi; 1971; 20(6):437-43. PubMed ID: 4326852
[No Abstract] [Full Text] [Related]
4. Biochemical, histochemical and electron-microscopic studies of 5-hydroxytryptamine in neoplastic mast cells.
Van Orden LS; Vugman I; Bensch KG; Giarman NJ
J Pharmacol Exp Ther; 1967 Nov; 158(2):195-205. PubMed ID: 6065143
[No Abstract] [Full Text] [Related]
5. The effect of cancer chemotherapy on lysosomal enzymic activities (acid phosphatase) of Ehrlich ascites carcinoma cells.
Todoruţiu C; Daicoviciu D
Morphol Embryol (Bucur); 1975; 21(3):219-26. PubMed ID: 129697
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC.
Das AK; Roy DK
Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682
[No Abstract] [Full Text] [Related]
7. Natural antibodies against the Ehrlich ascites mouse tumour in sera of irradiated goats, identified by complement consumption.
Oravec C; Cambelová J
Neoplasma; 1971; 18(2):161-72. PubMed ID: 5577314
[No Abstract] [Full Text] [Related]
8. Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.
Matthews TJ; Collins JJ; Roloson GJ; Thiel HJ; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2332-6. PubMed ID: 7229377
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
Valguarnera G
Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
[No Abstract] [Full Text] [Related]
10. [Morphological changes of the cells of Ehrlich's experimental ascites carcinoma in the course of immunological lysis].
Chibowski D
Ann Univ Mariae Curie Sklodowska Med; 1964; 19():465-78. PubMed ID: 4159442
[No Abstract] [Full Text] [Related]
11. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein.
Yamamoto Y; Tadatomo Y; Okamura S
Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471
[No Abstract] [Full Text] [Related]
12. THE EFFECTS OF ANTIBODIES ON CELLS. I. BIOCHEMICAL AND HISTOCHEMICAL EFFECTS OF ANTIBODIES AND COMPLEMENT ON ASCITES TUMOUR CELLS.
DUMONDE DC; BITENSKY L; CUNNINGHAM GJ; CHAYEN J
Immunology; 1965 Jan; 8(1):25-36. PubMed ID: 14245309
[TBL] [Abstract][Full Text] [Related]
13. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
Dauphinee MJ; Talal N; Witz IP
J Immunol; 1974 Sep; 113(3):948-53. PubMed ID: 4413555
[No Abstract] [Full Text] [Related]
14. [Transport studies, morphological, morphometric and histochemical studies on the behavior of the intestinal mucosa in the surgically bypassed jejunal segment of rats].
Menge H; Bloch R; Schaumlöffel E; Riecken EO
Z Gesamte Exp Med Einschl Exp Chir; 1970; 153(1):74-90. PubMed ID: 4325067
[No Abstract] [Full Text] [Related]
15. [Histochemical and histoenzymological changes caused by soluble antigens during the primary and secondary immune response].
Ciplea AG; Pop A; Bona C
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):713-8. PubMed ID: 5521123
[No Abstract] [Full Text] [Related]
16. THE EFFECTS OF ANTIBODIES ON CELLS. II. CHANGES IN THE ELECTROPHORETIC MOBILITY OF ASCITES TUMOUR CELLS TREATED WITH ANTIBODIES AND COMPLEMENT.
FORRESTER JA; DUMONDE DC; AMBROSE EJ
Immunology; 1965 Jan; 8(1):37-48. PubMed ID: 14245310
[TBL] [Abstract][Full Text] [Related]
17. [Effect of pulsed laser radiation on the lysosomes of Ehrlich ascitic tumor cells].
Moskalik KG; Riazanov EM; Lazo VV; Merkle K
Vopr Onkol; 1982; 28(4):42-4. PubMed ID: 7090268
[TBL] [Abstract][Full Text] [Related]
18. Natural antibodies in normal human sera againist the Ehrlich mouse ascites tumour identified with the aid of complement components, utilizing classical reagents.
Oravec C; Cambelová J
Neoplasma; 1971; 18(2):141-59. PubMed ID: 5577313
[No Abstract] [Full Text] [Related]
19. [The duration of the inhibitory influence of antironidase serum and its gamma-globulin fraction on the mitotic ACTIVITY OF TUMOR CELLS].
Sukhorukikh SV
Biull Eksp Biol Med; 1965 Nov; 60(11):96-8. PubMed ID: 4164707
[No Abstract] [Full Text] [Related]
20. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
Okubo S
Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
